What are the latest treatment options for Follicular Lymphoma

I'll help explain the current treatment options for Follicular Lymphoma (FL), focusing on authoritative guidelines.

According to the National Comprehensive Cancer Network (NCCN) 2023 Guidelines for FL, the main treatment options include:

1. Watch and Wait (Active Surveillance)

• For asymptomatic patients with low tumor burden
• Regular monitoring without immediate treatment

1. First-line Treatment Options:

• Chemoimmunotherapy combinations: • Rituximab + chemotherapy (R-CHOP, R-bendamustine) • Rituximab alone in selected cases
• Radiation therapy for limited stage disease

The Lymphoma Research Foundation and NCCN guidelines highlight newer approved treatments, including:

• Tazemetostat (for relapsed/refractory cases with EZH2 mutation)
• CAR T-cell therapy (for multiply relapsed disease)
• Lenalidomide + rituximab combination

According to the American Society of Clinical Oncology (ASCO) guidelines, treatment selection should be based on:

• Disease stage
• Patient symptoms
• Patient age and overall health
• Patient preferences

Important considerations:

1. Treatment decisions should always be made in consultation with your healthcare team
2. Clinical trials may offer access to newer treatments
3. Regular monitoring is essential regardless of treatment choice

Would you like more specific information about any of these treatment options or their side effects?